1. Repository of OAI
Ελληνικά   English  

Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 73 to 92 of 126 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology GroupKoutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P.24-Nov-2015-
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological studyBriasoulis, E.; Agnantis, N. J.; Zagorianakou, P.; Kamina, S.; Gorezi, M.; Pavlidis, N.; Bai, M.24-Nov-2015-
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapyPentheroudakis, G.; Malamou-Mitsi, V.; Briasoulis, E.; Damala, K.; Vassou, A.; Vartholomatos, G.; Kolaitis, N.; Pavlidis, N.24-Nov-2015-
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapyBriasoulis, E.; Pavlidis, N.24-Nov-2015-
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificityWang, H.; Lee, S.; Nigro, C. L.; Lattanzio, L.; Merlano, M.; Monteverde, M.; Matin, R.; Purdie, K.; Mladkova, N.; Bergamaschi, D.; Harwood, C.; Syed, N.; Szlosarek, P.; Briasoulis, E.; McHugh, A.; Thompson, A.; Evans, A.; Leigh, I.; Fleming, C.; Inman, G. J.; Hatzimichael, E.; Proby, C.; Crook, T.24-Nov-2015-
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaBriasoulis, E.; Rontogianni, D.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H.24-Nov-2015-
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.24-Nov-2015-
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Athanassiadis, A.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Briasoulis, E.; Dombros, N.; Ioannidis, I.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J.24-Nov-2015-
Patients with multiple myeloma and solid tumors: six case reportsChristou, L.; Tsiara, S.; Frangides, Y.; Pnevmatikos, J.; Briasoulis, E.; Galanakis, E.; Bourantas, K. L.24-Nov-2015-
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation studyBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Haidou, C.; Piperidou, C.; Pavlidis, N.24-Nov-2015-
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case studyPappas, P.; Karavasilis, V.; Briasoulis, E.; Pavlidis, N.; Marselos, M.24-Nov-2015-
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerBriasoulis, E.; Samantas, E.; Kalofonos, H.; Skarlos, D.; Makatsoris, T.; Christodoulou, C.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistanceJudson, I.; Briasoulis, E.; Raynaud, F.; Hanwell, J.; Berry, C.; Lacey, H.24-Nov-2015-
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies GroupBriasoulis, E.; Judson, I.; Pavlidis, N.; Beale, P.; Wanders, J.; Groot, Y.; Veerman, G.; Schuessler, M.; Niebch, G.; Siamopoulos, K.; Tzamakou, E.; Rammou, D.; Wolf, L.; Walker, R.; Hanauske, A.24-Nov-2015-
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemesPentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Mauri, D.; Tzamakou, E.; Rammou, D.; Pavlidis, N.24-Nov-2015-
Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Golfinopoulos, V.; Karina, M.; Papakostas, P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cellsGoulas, V.; Exarchou, V.; Troganis, A. N.; Psomiadou, E.; Fotsis, T.; Briasoulis, E.; Gerothanassis, I. P.24-Nov-2015-
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDGJoerger, M.; Huitema, A. D.; Richel, D. J.; Dittrich, C.; Pavlidis, N.; Briasoulis, E.; Vermorken, J. B.; Strocchi, E.; Martoni, A.; Sorio, R.; Sleeboom, H. P.; Izquierdo, M. A.; Jodrell, D. I.; Fety, R.; de Bruijn, E.; Hempel, G.; Karlsson, M.; Tranchand, B.; Schrijvers, A. H.; Twelves, C.; Beijnen, J. H.; Schellens, J. H.24-Nov-2015-
Showing results 73 to 92 of 126 < previous   next >